Facebook Linkedin Mail Twitter
Facebook Linkedin Mail Twitter

Tag: AQUA study

NephroSant launches two-year AQUA study involving 2,000 kidney transplant recipients

NephroSant has today announced enrolment of the first patient in its AQUA (Assessment of QSant for underlying allograft rejection) study. Eligible participants will have...
Renal Interventions

Write to us
Editor: George Barker [email protected]
Advertising: Rav Pankhania [email protected]


United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]

Terms and Conditions | Privacy Policy

Facebook Linkedin Mail Twitter